Cytomegalovirus in transplantation - challenging the status quo.
about
Cytomegalovirus-induced immunopathology and its clinical consequencesPre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipientsCytomegalovirus infection in immunosuppressed patients after kidney transplantationCytomegalovirus infection in transplant recipientsCytomegalovirus: pathogen, paradigm, and puzzleTemporal response of the human virome to immunosuppression and antiviral therapyRecent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Human Cytomegalovirus (HCMV) - Revised.Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel diseaseLower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipientsExpansion of a unique CD57⁺NKG2Chi natural killer cell subset during acute human cytomegalovirus infectionDifferential decay kinetics of human cytomegalovirus glycoprotein B genotypes following antiviral chemotherapy.Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence.Novel decay dynamics revealed for virus-mediated drug activation in cytomegalovirus infection.Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients.The impact of cytomegalovirus infection ≥1 year after primary renal transplantation.Rare presentations of cytomegalovirus infection in renal allograft recipients.Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.Clinical significance of quantitative and qualitative detection of BK and JC virus in blood and urine of renal transplantation recipients.Long term complications following 54 consecutive lung transplantsEpigenetic control of cytomegalovirus latency and reactivation.Review of nonimmunological causes for deteriorated graft function and graft loss after transplantation.Complications post renal transplantation: literature focus on BK virus nephropathy and diagnostic tools actually available.Embryonic pig pancreatic tissue for the treatment of diabetes in a nonhuman primate model.A Model for HCMV Infection in Immunosuppressed Patients.Maribavir: a novel antiviral agent with activity against cytomegalovirus.Neutrophil gelatinase-associated lipocalin in kidney transplantation is an early marker of graft dysfunction and is associated with one-year renal function.Age-dependent association between low frequency of CD27/CD28 expression on pp65 CD8+ T cells and cytomegalovirus replication after transplantation.Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Role of bacterial infections in allograft rejection.Proliferation signal inhibitors and post-transplant malignancies in heart transplantation: practical clinical management questions.Valganciclovir to prevent or treat cytomegalovirus disease in organ transplantation.Proliferation signal inhibitor toxicities after thoracic transplantation.Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology.Quantification of cytomegalovirus viral load.Treatment of cytomegalovirus infections beyond acute disease to improve human health.Epigenetic regulation of human cytomegalovirus latency: an update.Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus.Is cytomegalovirus infection dangerous in cytomegalovirus-seropositive recipients after liver transplantation?The Cell Biology of Cytomegalovirus: Implications for Transplantation.
P2860
Q21195897-B3B50B3F-D489-4C68-9E52-57D99E430A7DQ24200991-09BBC28E-D8CF-4650-B7C6-71B44181B97EQ26740169-B4DF8DD7-5A53-49E2-BA83-623F33C359BAQ26801802-6415D211-47EA-46AB-AD5B-63BAD8B111B7Q33351523-2625D73A-44C2-481B-AE11-0068C850D326Q33902789-0A067615-F6A5-40E8-B2F5-84227C010900Q34349745-4ACAFE3C-1EB3-4174-BA53-C2C4072D4E9FQ34625453-07F7C497-E712-4714-AD7B-CBE01D404257Q34644510-B3457F64-6B43-4BDC-B89D-53DA4789ABA7Q35064406-ADBC827D-6C8F-421C-A14A-387413752686Q35202828-0E1CCE56-B4C2-4E85-B3AF-689BC862DED3Q35895301-53027C29-D740-4941-BBFD-F26611C05AAFQ36214992-B80D5E4D-FA2C-4CCB-B127-C0098CF557FDQ36346012-99654773-83A2-4CA1-97D2-EB2CAD36A398Q36516318-4EAE1231-B8AD-4E70-B6DA-7B2780F6D404Q36558077-C02D4A13-4B43-42B2-9EDB-2AC42CA1BA2FQ36734332-26DBFA31-0232-479E-9B61-EF846C426C9BQ36862292-90D07320-29B7-4F4A-BE32-89835F048939Q36876460-B3EEBFC5-0DE4-4CB1-864B-D3C3F1806846Q36948920-48645727-4466-4A5A-90A3-B3837818310FQ37015743-B9EC3F52-9CB2-49E3-97CA-EF6233C444EFQ37081669-7D3606AC-EB30-40E0-9F61-2AF4E02538A2Q37100327-6B56D105-C89F-46F3-81F0-DB73A2BEFAEFQ37208835-9ADD5B6D-492C-411E-B61E-B4ED9290D4EBQ37234809-4854BF30-581F-4B52-95E2-4A4A5085BCA0Q37242251-433111C2-A099-4308-B5FF-71B398CFDC4DQ37322729-4D2B829D-6000-4109-9078-D46E5C9736ABQ37374672-B1FE3678-B149-4E93-B49E-C73B6B052EDBQ37667998-12987373-B758-4107-9454-AF754C72221AQ37754716-369633D4-14CB-45E6-BB58-161FE60DE6E6Q37876951-26822E5B-6DAB-4723-93F8-347E87D6D4DBQ37949634-643D61BD-E79B-4327-B398-871BB0EFF243Q38044748-150FCAEF-E466-4116-88BE-7B724A4CDF08Q38053067-A7E9E76E-8F6D-44E2-ABF8-751E12CAD08DQ38171537-E9339C69-11D3-46B6-B379-CAA26E59549FQ38176940-72B58663-DD57-476D-9C18-60C221258CF4Q38272313-9AD03FF7-807A-4DD1-992A-46A41336A7BAQ38415861-CC85EE49-8CE5-4FF7-B470-EE039E11D243Q38475761-6A235531-5F9D-4E33-8370-63B194A2C810Q38779938-D5A72F1F-96E3-4885-8E2E-732BB76A6985
P2860
Cytomegalovirus in transplantation - challenging the status quo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Cytomegalovirus in transplantation - challenging the status quo.
@en
type
label
Cytomegalovirus in transplantation - challenging the status quo.
@en
prefLabel
Cytomegalovirus in transplantation - challenging the status quo.
@en
P2093
P2860
P50
P1476
Cytomegalovirus in transplantation - challenging the status quo.
@en
P2093
Hans J Schlitt
Jay A Fishman
Julian Torre-Cisneros
Manuel Pascual
Marc E Uknis
Richard Freeman
P2860
P304
P356
10.1111/J.1399-0012.2006.00618.X
P577
2007-03-01T00:00:00Z